Unit of Geriatrics and Internal Medicine, National Institute of Gastroenterology "Saverio de Bellis", Research Hospital, 70013, Castellana Grotte, BA, Italy.
Unit of Data Sciences and Technology Innovation for Population Health, National Institute of Gastroenterology "Saverio de Bellis", Research Hospital, 70013, Castellana Grotte, BA, Italy.
Sci Rep. 2021 Dec 16;11(1):24084. doi: 10.1038/s41598-021-03583-3.
Comprehensive screening for non-alcoholic fatty liver disease (NAFLD) may help prompt clinical management of fatty liver disease. A family history, especially of diabetes, has been little studied as a predictor for NAFLD. We characterized the cross-sectional relationship between a family history of type 2 diabetes (FHT2D) and NAFLD probability in 1185 diabetes-free Apulian (Southern-Italy) subjects aged > 20 years with overweight or obesity not receiving any drug or supplementation. Clinical data and routine biochemistry were analysed. NAFLD probability was defined using the fatty liver index (FLI). A first-degree FHT2D was assessed by interviewing subjects and assigning a score of 0, 1, or 2 if none, only one, or both parents were affected by type 2 diabetes mellitus (T2DM). Our study population featured most females (70.9%, N = 840), and 48.4% (N = 574) of the sample had first-degree FHT2D. After dividing the sample by a FHT2D, we found a higher BMI, Waist Circumference (WC), and diastolic blood pressure shared by FHT2D subjects; they also showed altered key markers of glucose homeostasis, higher triglyceride levels, and worse liver function. FLI scores were significantly lower in subjects without a first-degree FHT2D. After running logistic regression models, a FHT2D was significantly associated with the NAFLD probability, even adjusting for major confounders and stratifying by age (under and over 40 years of age). A FHT2D led to an almost twofold higher probability of NAFLD, regardless of confounding factors (OR 2.17, 95% CI 1.63 to 2.89). A first-degree FHT2D acts as an independent determinant of NAFLD in excess weight phenotypes, regardless of the age group (younger or older than 40 years). A NAFLD risk assessment within multidimensional screening might be useful in excess weight subjects reporting FHT2D even in the absence of diabetes.
全面筛查非酒精性脂肪性肝病 (NAFLD) 可能有助于促进脂肪性肝病的临床管理。家族史,尤其是糖尿病家族史,作为 NAFLD 的预测因子,研究甚少。我们描述了在 1185 名年龄大于 20 岁、超重或肥胖且未服用任何药物或补充剂的无糖尿病的阿普利亚(意大利南部)人群中,2 型糖尿病家族史 (FHT2D) 与 NAFLD 概率之间的横断面关系。分析了临床数据和常规生化指标。使用脂肪肝指数 (FLI) 定义 NAFLD 概率。通过访谈受试者并给与 0、1 或 2 分来评估一级 FHT2D,如果没有、仅有一位或两位父母患有 2 型糖尿病 (T2DM)。我们的研究人群以女性为主 (70.9%,N=840),样本中有 48.4% (N=574) 的人有一级 FHT2D。根据 FHT2D 对样本进行分组后,我们发现 FHT2D 受试者的 BMI、腰围 (WC) 和舒张压更高;他们的糖代谢关键标志物也发生改变,甘油三酯水平更高,肝功能更差。无一级 FHT2D 的受试者的 FLI 评分明显较低。进行逻辑回归模型后,即使在调整主要混杂因素并按年龄(40 岁以下和以上)分层后,FHT2D 仍与 NAFLD 概率显著相关。FHT2D 使 NAFLD 的发生概率增加近两倍,无论是否存在混杂因素 (OR 2.17,95%CI 1.63 至 2.89)。一级 FHT2D 是超重表型中 NAFLD 的独立决定因素,无论年龄组(40 岁以下或以上)如何。即使在没有糖尿病的情况下,超重受试者报告有 FHT2D 时,在多维筛查中进行 NAFLD 风险评估可能是有用的。